Ad
related to: phq 9 pdf gad 7
Search results
Results From The WOW.Com Content Network
The PHQ-9, GAD-7, and the PHQ-15 were combined to create the PHQ-somatic, anxiety, depressive symptoms (PHQ-SADS) [2] and includes questions regarding panic attacks (after the GAD-7 section). Though less commonly used, there are also brief versions of the PHQ-9 and GAD-7 that may be useful as screening tools in some settings.
The GAD-7 is a seven-item anxiety screening instrument developed in 2006 with a similar format to that of the PHQ-9. [20] Total scores range from 0 to 21 with scores of 5, 10, and 15 indicating mild, moderate, and severe anxiety. Unlike the PHQ-9, clinicians use the GAD-7 to assess the severity of anxiety only.
The GAD-7 has further been studied and validated in numerous other samples and settings. [9] It has been shown to correlate with other measures of anxiety and has been considered superior to other questionnaires. [10] [11] [12] The GAD-7 has been evaluated in samples of both children and young individuals [13] as well as older adults.
Generalized Anxiety Disorder 7 (GAD-7) [4] [5] Hamilton Anxiety Scale (HAM-A) [6] [7] Hospital Anxiety and Depression Scale; Panic and Agoraphobia Scale (PAS) Panic Disorder Severity Scale (PDSS) PTSD Symptom Scale – Self-Report Version; Screen for child anxiety related disorders; Social Phobia and Anxiety Inventory-Brief form; Social Phobia ...
[1] [2] Others include the Beck Depression Inventory, the CORE-OM, Generalized Anxiety Disorder 7 (GAD-7) and the Patient Health Questionnaire (PHQ-9), amongst others. [3] By comparing scores before, during and after completion of talking therapy, the measure enables calculation of a change score.
Using a cut-off of 8 the GAD-7 has a sensitivity of 92% and specificity of 76% for diagnosis generalized anxiety disorder. The following cut-offs correlate with level of anxiety severity: Score 0-4: Minimal Anxiety; Score 5-9: Mild Anxiety; Score 10-14: Moderate Anxiety; Score greater than 15: Severe Anxiety
The GAD-7 has a sensitivity of 57-94% and a specificity of 82-88% in the diagnosis of general anxiety disorder. [7] All screening questionnaires, if positive, should be followed by clinical interview including assessment of impairment and distress, avoidance behaviors, symptom history and persistence to definitively diagnose an anxiety disorder ...
The clinical outcomes on the K-10, PHQ-9 and GAD-7 are consistent with those observed in Australian benchmarking studies. [10] The magnitude of treatment benefits at MindSpot are comparable with those reported in the English Improving Access to Psychological Therapies (IAPT) programme [ 11 ] and in benchmarking studies of face-to-face therapy.